The Role of NMDA, GLUR4, NF-κB, and Nrf2 in Glaucoma Pathophysiology: Evidence from Wistar Rat Model
Journal of Biomedicine and Translational Research · 30.04.2026 · 12 (1) · 65-70
DOI: 10.14710/jbtr.v12i1.30645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedicine and Translational Research, online erschienen am 30.04.2026. Verfasst von Maharani Maharani und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
Glaucoma is a neurodegenerative disorder involving retinal ganglion cell loss. Elevated intraocular pressure activates the N-methyl-D-aspartate (NMDA) and Glutamate Receptor 4 (GluR4), inducing oxidative stress via the nuclear factor-kappa B (NF-κB) pathway and triggering antioxidant responses through the nuclear factor erythroid 2-related factor 2 (NRF2) pathway, which contributes to disease progression and informs therapeutic insights.
Objective
To explore NMDA, GluR4, NF-κB, and NRF2 roles in glaucoma pathophysiology and identify therapeutic targets using Wistar rat models.
Methods
This experimental research was conducted using a post-test-only control group design. Fourteen male Wistar rats were divided into two groups (n = 7). The glaucoma group underwent episcleral veincauterization (EVC) to induce a high intraocular pressure (IOP), whereas the control group remained untreated. Four weeks after EVC, evaluations included the expression of NMDA, GluR4, NF-κB, and NRF2 receptors. Statistical significance was defined as a p-value < 0.05. Statistical analysis was performed using a parametric independent t-test and a Mann-Whitney U test.
Results
The mean NMDA expression was significantly higher in the glaucoma group (14.50 ± 4.23) compared to the control group (7.74 ± 3.24, p=0.006). Similarly, the mean GluR4 expression was elevated in the glaucoma group (10.77 ±2.40) compared to the control group (3.03 ± 4.05, p = 0.012). The mean NF-κB expression was 14.96 ± 4.87 in the glaucoma group, significantly higher than 6.72 ± 1.84 in the control group (p = 0.003). Conversely, the mean NRF2 expression was significantly lower in the glaucoma group (3.98 ± 1.10) than in the control group (7.18 ± 1.61, p < 0.001).
Conclusion
The study highlights significant changes in all four variables, where NMDA, GluR4, NF-κB expressions were higher, and NRF2 expression was lower
Zitieren
APA
Maharani, M., Kartasasmita, A. S., Rahmi, F. L., & Rachmawati, B. (2026). The Role of NMDA, GLUR4, NF-κB, and Nrf2 in Glaucoma Pathophysiology: Evidence from Wistar Rat Model. Journal of Biomedicine and Translational Research, 12(1), 65-70. https://doi.org/10.14710/jbtr.v12i1.30645
Vancouver
Maharani M, Kartasasmita AS, Rahmi FL, Rachmawati B. The Role of NMDA, GLUR4, NF-κB, and Nrf2 in Glaucoma Pathophysiology: Evidence from Wistar Rat Model. Journal of Biomedicine and Translational Research. 2026;12(1):65-70. doi:10.14710/jbtr.v12i1.30645
BibTeX
@article{Maharani2026,
author = {Maharani, Maharani and Kartasasmita, Arief Sjamsulaksan and Rahmi, Fifin Luthfia and Rachmawati, Banundari},
title = {The Role of NMDA, GLUR4, NF-κB, and Nrf2 in Glaucoma Pathophysiology: Evidence from Wistar Rat Model},
journal = {Journal of Biomedicine and Translational Research},
year = {2026},
volume = {12},
number = {1},
pages = {65--70},
doi = {10.14710/jbtr.v12i1.30645}
}
EUVIMED